Abstract
THE endothelial cell-specific vascular endothelial growth factor (VEGF)1–5 and its cellular receptors Flt-1 (refs 6,7) and Flk-1 (refs 8,9) have been implicated in the formation of the embryonic vasculature. This is suggested by their colocalized expression during embryogenesis10,11 and the impaired vessel formation in Flk-1 (ref. 12) and Flt-1 (ref. 13) deficient embryos. However, because Flt-1 also binds placental growth factor14,15, a VEGF homologue, the precise role of VEGF was unknown. Here we report that formation of blood vessels was abnormal, but not abolished, in heterozygous VEGF-deficient (VEGF+/-) embryos, generated by aggregation of embryonic stem (ES) cells with tetraploid embryos (T-ES)16,17, and even more impaired in homozygous VEGF-deficient (VEGF-/-) T-ES embryos, resulting in death at mid-gestation. Similar phenotypes were observed in F1-VEGF-/- embryos, generated by germline transmission. We believe that this heterozygous lethal phenotype, which differs from the homozygous lethality in VEGF-receptor-deficient embryos, is unprecedented for a targeted autosomal gene inacti-vation, and is indicative of a tight dose-dependent regulation of embryonic vessel development by VEGF.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klagsbrun, M. & Soker, S. Curr. Biol. 3, 699–702 (1993).
Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M. Am. J. Path. 146, 1029–1039 (1995).
Plate, K. H., Breier, G. & Risau, W. Brain Path. 4, 207–218 (1994).
Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T. & Levi, B-Z. Prog. Growth Factor Res. 5, 89–97 (1994).
Ferrara, N. Trends cardiovasc. Med. 3, 244–250 (1993).
Shibuya, M. et al. Oncogene 5, 519–524 (1990).
Devries, C. et al. Science 255, 989–991 (1992).
Millauer, B. et al. Cell 72, 835–846 (1993).
Mustonen, T. & Alitalo, K. J. Cell Biol. 129, 895–898 (1995).
Breier, G., Albrecht, U., Sterrer, S. & Risau, W. Development 114, 521–532 (1992).
Breier, G., Clauss, M. & Risau, W. Devl. Dynam. 204, 228–239 (1995).
Shalaby, F. et al. Nature 376, 62–66 (1995).
Fong, G.-H., Rossant, J., Gertsenstein, M. & Breitman, M. L. Nature 376, 66–70 (1995).
Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. & Persico, M. G. Proc. natn. Acad. Sci. U.S.A. 88, 9276–9271 (1991).
Park, J. E., Chen, H. H., Winer, J., Houck, K. A. & Ferrara, N. J. biol. Chem. 269, 25646–25654 (1994).
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J. C. Proc. natn. Acad. Sci. U.S.A. 90, 8424–8428 (1993).
Nagy, A. & Rossant, J. in Gene targeting. A Practical Approach (ed. Joyner, A. L) 147–180 (IRL, Oxford, 1994).
Tischer, E. et al. J. biol. Chem. 266, 11947–11954 (1991).
Claffey, K. P., Senger, D. R. & Spiegelman, B. M. Biochim. biophys. Acta 1246, 1–9 (1995).
Pötgen, A. J. G. et al. J. biol. Chem. 269, 32879–32885 (1994).
Friedrich, G. & Soriano, P. Genes Dev. 5, 1513–1523 (1991).
Puri, M., Rossant, J., Alitalo, K., Bernstein, A. & Partanen, J. EMBO J. 14, 5884–5891 (1995).
Risau, W. & Flamme, I. A. Rev. Cell. Dev. Biol. 11, 73–92 (1995).
Alon, T. et al. Nature Med. 1, 1024–1028 (1995).
Tybulewicz, V. et al. Cell 65, 1153–1163 (1991).
Carmeliet, P. et al. J. clin. Invest. 92, 2746–2755 (1993).
Risau, W. et al. Development 102, 471–478 (1988).
Stavri, G. T. et al. FEBS Lett. 358, 311–315 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carmeliet, P., Ferreira, V., Breier, G. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996). https://doi.org/10.1038/380435a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/380435a0
This article is cited by
-
Sex, hormones and cerebrovascular function: from development to disorder
Fluids and Barriers of the CNS (2024)
-
The use of anti-VEGF agents in pregnancy
Eye (2024)
-
Targeting angiogenesis in oncology, ophthalmology and beyond
Nature Reviews Drug Discovery (2023)
-
Angiogenesis after ischemic stroke
Acta Pharmacologica Sinica (2023)
-
Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer
Communications Biology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.